Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR01102
|
|||||
Drug Name |
Vortioxetine
|
|||||
Synonyms |
1-(2-((2,4-Dimethylphenyl)thio)phenyl)piperazine; 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]-piperazine; 1-[2-(2,4-dimethylphenyl)sulfanylphenyl]piperazine; 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine; 1-[2-[(2,4-Dimethylphenyl)thio]phenyl]piperazine; 1-{2-[(2,4-dimethylphenyl)sulfanyl]phenyl}piperazine; 3O2K1S3WQV; 508233-74-7; Brintellix (TN); CHEBI:76016; CHEMBL2204360; Lu AA21004; Lu-AA21004; Piperazine, 1-[2-[(2,4-dimethylphenyl)thio]phenyl]-; Trintellix; UNII-3O2K1S3WQV; VORTIOXETINE
|
|||||
Drug Type |
Small molecular drug
|
|||||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C18H22N2S
|
|||||
Canonical SMILES |
CC1=CC(=C(C=C1)SC2=CC=CC=C2N3CCNCC3)C
|
|||||
InChI |
InChI=1S/C18H22N2S/c1-14-7-8-17(15(2)13-14)21-18-6-4-3-5-16(18)20-11-9-19-10-12-20/h3-8,13,19H,9-12H2,1-2H3
|
|||||
InChIKey |
YQNWZWMKLDQSAC-UHFFFAOYSA-N
|
|||||
CAS Number |
CAS 508233-74-7
|
|||||
Pharmaceutical Properties | Molecular Weight | 298.4 | Topological Polar Surface Area | 40.6 | ||
Heavy Atom Count | 21 | Rotatable Bond Count | 3 | |||
Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 3 | |||
XLogP |
4.2
|
|||||
PubChem CID | ||||||
PubChem SID |
134339122
, 135268324
, 135626902
, 137031414
, 141291936
, 14942974
, 160676538
, 160874200
, 162224457
, 163349926
, 163409417
, 163847660
, 164347389
, 164777223
, 172919848
, 175266271
, 178103923
, 185968494
, 187072019
, 189628085
, 198993777
, 210024065
, 210275229
, 210280867
, 223595856
, 224449304
, 226587298
, 242073286
, 24232104
, 244850411
, 249828940
, 250182630
, 251899315
, 252055744
, 252090010
, 252313288
, 252499412
, 46062622
, 74967215
|
|||||
TTD Drug ID |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.